Comment on

• Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

  Johnson JA, Li JF, Morris L, Martinson N, Gray G, McIntyre J, Heneine W. Johnson JA, et al. J Infect Dis. 2005 Jul 1;192(1):16-23. doi: 10.1086/430741. Epub 2005 Jun 1. J Infect Dis. 2005. PMID: 15942889
• Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

  Flys T, Nissley DV, Claassen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH. Flys T, et al. J Infect Dis. 2005 Jul 1;192(1):24-9. doi: 10.1086/430742. Epub 2005 Jun 1. J Infect Dis. 2005. PMID: 15942890
• Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

  Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T. Eshleman SH, et al. J Infect Dis. 2005 Jul 1;192(1):30-6. doi: 10.1086/430764. Epub 2005 Jun 1. J Infect Dis. 2005. PMID: 15942891